📰 Medication Guide News
Page 33 - Medication Guide News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Medication Guide. Real-time updates on events, politics, business and more.
November 10, 2022
(BPT) - Sponsored by PfizerLiving with moderate-to-severe atopic dermatitis (AD) – also known as eczema – can be challenging.[1] In addition to having the physical burden that includes flare-ups of red, itchy, painful skin, there is also th...
November 10, 2022
Total nine-month revenues of €249.9 million, a ~ 3.5-fold increase compared to 2021 Product sales of €74.4 million (vs €45.5 million in the first nine months of
November 8, 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it would present new data across its rheumatology portfolio, including RINVOQ® (upadacitinib) for...
November 8, 2022
Thirty-six abstracts underscore AbbVies commitment to advancing research to help more people living with rheumatic diseasesAdditional analysis of...
November 3, 2022
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 13 abstracts will be presented at the American Society of Hematology (ASH) Annual...
November 3, 2022
Key data includes results for intravenous administration of Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) in Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Patients DUBLIN
November 2, 2022
/PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is inviting people across the country to take a "Moment for You" on Wednesday, November 16...
October 25, 2022
Ad hoc announcement pursuant to Art. 53 LR Idorsia announces financial results for the first nine months of 2022 - QUVIVIQ becoming a global brand Allschwil, Switzerland - October 25, 2022Idorsia
October 24, 2022
Data illustrates AbbVies commitment to providing research and innovative solutions that support patients with high disease burden and unmet needOral presentations address treatment of moderate to severe Crohns disease, including